Cargando…

Whole-genome sequencing reveals the evolutionary trajectory of HBV-related hepatocellular carcinoma early recurrence

Patients with hepatocellular carcinoma (HCC) have poor long-term survival following curative resection because of the high rate of tumor early recurrence. Little is known about the trajectory of genomic evolution from primary to early-recurrent HCC. In this study, we performed whole-genome sequencin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Shao-Lai, Zhou, Zheng-Jun, Song, Cheng-Li, Xin, Hao-Yang, Hu, Zhi-Qiang, Luo, Chu-Bin, Luo, Yi-Jie, Li, Jia, Dai, Zhi, Yang, Xin-Rong, Shi, Ying-Hong, Wang, Zheng, Huang, Xiao-Wu, Fan, Jia, Zhou, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789859/ https://www.ncbi.nlm.nih.gov/pubmed/35078970 http://dx.doi.org/10.1038/s41392-021-00838-3

Ejemplares similares

Association of KRAS Variant Subtypes With Survival and Recurrence in Patients With Surgically Treated Intrahepatic Cholangiocarcinoma
por: Zhou, Shao-Lai, et al.
Publicado: (2021)

MACROD2 deficiency promotes hepatocellular carcinoma growth and metastasis by activating GSK-3β/β-catenin signaling
por: Zhou, Zheng-Jun, et al.
Publicado: (2020)

Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation
por: Hu, Jie, et al.
Publicado: (2011)

Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients
por: Zhu, Gui-Qi, et al.
Publicado: (2019)

LINC01133 promotes hepatocellular carcinoma progression by sponging miR‐199a‐5p and activating annexin A2
por: Yin, Dan, et al.
Publicado: (2021)

Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resection
por: Hu, Zhi-Qiang, et al.
Publicado: (2020)

Whole exome sequencing reveals the genetic heterogeneity and evolutionary history of primary gliomas and matched recurrences
por: Xu, Peng-Fei, et al.
Publicado: (2022)

Overexpression of semaphorin 3A promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma after curative resection
por: Hu, Zhi-Qiang, et al.
Publicado: (2016)

Identification of Histone Deacetylase 3 as a Biomarker for Tumor Recurrence Following Liver Transplantation in HBV-Associated Hepatocellular Carcinoma
por: Wu, Li-Ming, et al.
Publicado: (2010)

Constructing the HBV-human protein interaction network to understand the relationship between HBV and hepatocellular carcinoma
por: Wu, Zhong-Jun, et al.
Publicado: (2010)

The spatial organization of intra-tumour heterogeneity and evolutionary trajectories of metastases in hepatocellular carcinoma
por: Zhai, Weiwei, et al.
Publicado: (2017)

Evolutionary trajectories of snake genes and genomes revealed by comparative analyses of five-pacer viper
por: Yin, Wei, et al.
Publicado: (2016)

Hepatitis B virus (HBV) receptors: Deficiency in tumor results in scant HBV infection and overexpression in peritumor leads to higher recurrence risk
por: Jing, Ying-Ying, et al.
Publicado: (2015)

Enchanced levels of apolipoprotein M during HBV infection feedback suppresses HBV replication
por: Gu, Jin-Gang, et al.
Publicado: (2011)

HBeAg induces liver sinusoidal endothelial cell activation to promote intrahepatic CD8 T cell immunity and HBV clearance
por: Xie, Xiaohong, et al.
Publicado: (2021)

Common evolutionary trajectory of short life-cycle in Brassicaceae ruderal weeds
por: Li, Ling-Zi, et al.
Publicado: (2023)

Radiomics‐based classification models for HBV‐related cirrhotic patients with covert hepatic encephalopathy
por: Luo, Sha, et al.
Publicado: (2020)

Preoperative risk stratification for early recurrence of HBV-related hepatocellular carcinoma after deceased donor liver transplantation: a five-eight model development and validation
por: Al-Ameri, Abdulahad Abdulrab Mohammed, et al.
Publicado: (2019)

Plasma Circulating Cell-free DNA Integrity as a Promising Biomarker for Diagnosis and Surveillance in Patients with Hepatocellular Carcinoma
por: Huang, Ao, et al.
Publicado: (2016)

Circulating soluble CD36 as a novel biomarker for progression and prognosis of HBV-related liver diseases
por: Cai, Chunxian, et al.
Publicado: (2022)

Detecting Circulating Tumor DNA in Hepatocellular Carcinoma Patients Using Droplet Digital PCR Is Feasible and Reflects Intratumoral Heterogeneity
por: Huang, Ao, et al.
Publicado: (2016)

T cell receptor repertoire profiling predicts the prognosis of HBV‐associated hepatocellular carcinoma
por: Lin, Kai‐Rong, et al.
Publicado: (2018)

HBV integrated genomic characterization revealed hepatocyte genomic alterations in HBV-related hepatocellular carcinomas
por: Yang, Ming, et al.
Publicado: (2020)

Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

Preoperative γ-glutamyl transpeptidase to platelet ratio (GPR) is an independent prognostic factor for HBV-related hepatocellular carcinoma after curative hepatic resection
por: Wang, Wan-Li, et al.
Publicado: (2016)

Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma
por: Kan, Zhengyan, et al.
Publicado: (2013)

HBx Mediated Increase of DDX17 Contributes to HBV-Related Hepatocellular Carcinoma Tumorigenesis
por: Dong, Mei-Ling, et al.
Publicado: (2022)

Recurrent HBV Integration Targets as Potential Drivers in Hepatocellular Carcinoma
por: Lin, Selena Y., et al.
Publicado: (2021)

Mistranslation can promote the exploration of alternative evolutionary trajectories in enzyme evolution
por: Zheng, Jia, et al.
Publicado: (2021)

The HBV Specially-Related Long Noncoding RNA HBV-SRL Involved in the Pathogenesis of Hepatocellular Carcinoma
por: Zhang, Cunzhen, et al.
Publicado: (2022)

Novel strategy of sirolimus plus thymalfasin and huaier granule on tumor recurrence of hepatocellular carcinoma beyond the UCSF criteria following liver transplantation: A single center experience
por: Zhou, Lin, et al.
Publicado: (2018)

Prediction of early recurrence and response to adjuvant Sorafenib for hepatocellular carcinoma after resection
por: Zheng, Liming, et al.
Publicado: (2021)

Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinoma
por: Tian, Meng-Xin, et al.
Publicado: (2019)

Evolutionary Trajectory of the Replication Mode of Bacterial Replicons
por: Xie, Bin-Bin, et al.
Publicado: (2021)

A lipid metabolism–based prognostic risk model for HBV–related hepatocellular carcinoma
por: Zhou, Lili, et al.
Publicado: (2023)

Bioinformatics analysis of the proteins interacting with LASP-1 and their association with HBV-related hepatocellular carcinoma
por: Kong, Fan-Yun, et al.
Publicado: (2017)

Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma
por: Gong, Wen-Feng, et al.
Publicado: (2017)

Erratum: Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

Serum Amino Acid Profiles Predict the Development of Hepatocellular Carcinoma in Patients with Chronic HBV Infection
por: Wu, Tao, et al.
Publicado: (2022)

Identification of cyclin B1 and Sec62 as biomarkers for recurrence in patients with HBV-related hepatocellular carcinoma after surgical resection
por: Weng, Li, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_c2bbdj17uvddgk62pcvr6spceq